phenotype, which we study in a cell-based model of PPCD generated using CRISPR-Cas9-44
INTRODUCTION 50
The zinc finger e-box binding homeobox 1 (ZEB1) gene encodes a transcription factor involved 51 in epithelial and endothelial cell plasticity critical in development, wound healing and cancer [1] . 52 ZEB1 is a master regulator of cell state transitions (CSTs), namely epithelial to mesenchymal 53 remains to be tested, and the classification of CEnC in the context of EMT and MET may be 76 revealed by the important role that ZEB1 plays in the maintenance of the CEnC phenotype. and provide evidence (transcriptomic and cell function) to support our hypothesis that a novel 100 MET-like process, termed endothelial to epithelial transition (EnET), best explains the PPCDphenotype. Importantly, key findings from the transcriptomic profiling of human PPCD 102 endothelium [17] were recapitulated in the ZEB1 knockout cell line, further supporting the utility 103 of the CRISPR-Cas9-mediated knockout of ZEB1 in CEnC to gain a better understanding of the 104 molecular factors central to the pathogenesis of PPCD. In addition, based on the evidence 105 provided here for EnET, we propose a corollary to the EMT/MET paradigm, in which EnET is 106 classified as a MET subtype that is characteristic of PPCD. 107
RESULTS 109

Transcriptomic analysis validates the ZEB1 +/-CEnC line as a viable cell-based model of 110
PPCD 111
We developed a ZEB1 +/-CEnC line to examine the effects of the monoallelic knockout of ZEB1 112 on various cellular processes. The mutation introduced by non-homologous end joining repair is a 113 frameshift that generated a premature stop codon, similar to many ZEB1 mutations associated 114 with PPCD3. Prior to utilizing the CEnC line to study the effects of ZEB1 knockout on cellular 115 processes, we determined the extent to which the line recapitulated one of the primary molecular 116 hallmarks of PPCD endothelium: an ectopic/increased expression of epithelial-specific (and/or 117 associated) genes ( Fig 1A) . We identified 1715 differentially expressed genes in PPCD 118 endothelium compared to age-matched controls, of which 920 were upregulated and 795 were 119 downregulated [17] . Comparison of the differentially expressed genes in PPCD with genes 120 highly-associated with ex vivo corneal epithelial cells (evCEpC) or with ex vivo corneal 121 endothelial cells (evCEnC) demonstrated that 26% (65/249) of evCEpC genes were upregulated 122 and 37% (40/108) of evCEnC genes were downregulated in PPCD endothelium, significantly 123 different from the expected percentages due to chance alone (p<0.01) (Fig 1A and S1 Fig) . epithelial-or endothelial-associated genes in PPCD was previously identified (Fig 1A) , the 170 expression of the encoded protein has not been determined for a majority of these genes. Due to 171 the scarcity of corneal endothelial tissue from affected individuals, we assessed protein 172 expression of one epithelial-associated protein, claudin 1 (CLDN1), and of one endothelial-173 associated protein, adenylate cyclase activating polypeptide 1 receptor type 1 (ADCYAP1R1), in 174 PPCD endothelium (Fig 1F) . While ectopic CLDN1 expression was observed in PPCD 175 endothelium, ADCYAP1R1 expression was markedly decreased in PPCD endothelium compared 176 with normal endothelium. Ninety percent (9/10) of the selected corneal epithelial-associated 177
genes showing increased/ectopic expression in PPCD endothelium also demonstrated 178 increased/ectopic expression in ZEB1 +/--LV cells; GRHL2 was not expressed (Fig 1G) . Similarly The effects of ZEB1 insufficiency on cell morphology were analyzed using phase-contrast 185 microscopy (Fig 2) . Cells for each cloned line were examined at sub-confluent (Fig 2A) and 186 confluent densities (Fig 2B) . 
ZEB1
+/+ -LV confluent cells, thus re-establishing an endothelial-like phenotype without 219
propelling them to a fibroblast-like phenotype, which occurred in ZEB1 +/+ cells in which ZEB1 220 levels were augmented (i.e., ZEB1 +/+ +LV). 221
To assess for significant differences in the morphologic characteristics of the cells in each 222 group, we measured the major-axis length (MAL) of each cell in the sub-confluent cultures for 223 the three clones in each group and graphed the data as a box-plot ( Fig 2C) . We used the MAL of A non-wounding cell migration assay was performed to assess the effect of reduced ZEB1 levels 238 on CEnC migration capacity (Fig 3) . Phase-contrast microscopy demonstrated that reduction of 239 
Reduced ZEB1 levels leads to decreased CEnC proliferation capacity 255
To determine the effect that decreased ZEB1 has on CEnC proliferation, we measured cell 256 proliferation in ZEB1 +/+ and ZEB1 +/-cell lines with transient ZEB1 lentivirus transduction (Fig 4) . 257
Two days after transduction, some of the cells were re-seeded to assess cell proliferation while 258 the remaining cells were lysed and prepared for Western blotting. ZEB1 Western blot confirmed 259 the expected relative ZEB1 protein levels in each of the four groups ( Fig 4A) . 
278
ZEB1 insufficiency leads to increased CEnC barrier function 279
To measure the role that ZEB1 plays in CEnC barrier function, we used electric cell-substrate 280 impedance sensing (ECIS). Barrier function was monitored for 96 hours after initial seeding of 281 cells at 100% confluence (Fig 5) . ZEB1 +/--LV CEnC demonstrated significantly increased 282 impedance (i.e., increased barrier function), compared with ZEB1 +/+ -LV cells (p<0.05) (Fig 5A) . 283 
ZEB1 insufficiency may affect ultraviolet radiation-induced apoptosis in CEnC 345
Corneal endothelial cell density decreases over an individual's lifetime, due in part to cell 346 apoptosis. To investigate the effect of reduced ZEB1 on CEnC apoptosis, we exposed ZEB1 +/+ +/-347 LV and ZEB1 +/-+/-LV CEnC to ultraviolet C (UVC) for 6 hours and measured phosphorylation 348 of tumor protein 53 (TP53), which is phosphorylated at Serine 15 during apoptosis (Fig 7) [25] . A 349 decrease in phosphorylated TP53 was observed in ZEB1 +/--LV cells compared with ZEB1 +/+ -LV 350 cells (Fig 7A) . Correspondingly, augmenting ZEB1 levels in both ZEB1 +/-(ZEB1 +/-+LV) and 351
ZEB1
+/+ (ZEB1 +/+ +LV) cells resulted in an increase in phosphorylated TP53 compared with 352
+/--LV and ZEB1 +/+ -LV cells, respectively. While none of these pairwise comparisons 353 demonstrated statistical significance, it is important to note that the p-value obtained for the 1-354 way ANOVA was significant (p=0.044), suggesting that the observed means for all four groups, 355 taken together, have a low likelihood of occurring by chance alone (Fig 7B) . Cas9 gene-editing technology. We now report the functional impact that stable monoallelic 397 knockout of ZEB1 has on corneal endothelial cells. 398
As a prerequisite to performing relevant functional studies, we validated our cell-based 399 model using a transcriptomic approach. Because of the nature of cell culture and immortalization, 400 we expected to observe differences that were not directly relevant to our disease model. 401
Nevertheless, as ZEB1 is robust at mediating EMT in disparate cell types, we concluded that the 402 "background" gene expression was not likely to play a significant role in our study, although this 403 Scientific), 20 µg/mL ascorbic acid (Sigma-Aldrich), 10 ng/mL recombinant human fibroblast 504 growth factor (basic), 100 µg/mL penicillin (Thermo Fisher Scientific), and 100 µg/mL 505 streptomycin (Thermo Fisher Scientific). HEK293T cells were grown in DMEM supplemented 506 with 10% fetal bovine serum, 100 µg/mL penicillin and µg/mL streptomycin. The cell lines were 507 maintained in a humidified chamber containing 5% CO 2 . 508 509
Cell line authentication 510
The HCEnC-21T cell line was produced from primary human corneal endothelial cells (sourced 511 from cadaveric corneas) using telomerase immortalization [24] . The authors showed that the cells 512 retained gene expression and functional characteristics of corneal endothelial cells. In addition, 513 after we obtained the cells (a gift from Dr. Ula Jurkunas), we characterized them using a 514 transcriptomics approach and identified the expression of a number of genes distinct for ex vivo 515 human corneal endothelial cells [11] . In this same study, we identified high expression of the 516 human telomerase reverse transcriptase gene, confirming the method used to immortalize the 517 cells. We also performed short tandem repeat (STR) analysis for the ZEB1 +/+ and ZEB1 +/-cell 518 lines. Genomic DNA was isolated from the cell lines using the FlexiGene DNA Kit (Qiagen). 519
Subsequently, authentication was performed using the PowerPlex 16 System (Promega), a 520 multiplex STR system that complies with ANSI/ATCC ASN-0002-2011 guidelines for cell line 521 authentication. The STR profiles generated for the cell lines were a perfect match to the STR 522 profile of the parental cell line [18] . 523 524
Generation of ZEB1
+/-cell line using CRISPR-Cas9 525
In Silico guide RNA (gRNA) Design 526
We designed our gRNA (Sigma Aldrich) to target the Cas9 nuclease to exon 4 of ZEB1 to ensure 527 that the encoded mutant proteins were dysfunctional and that all known splice variants would be 528 affected (S2A Fig.) . The design was performed using the crispr.MIT.edu design tool that 529 identifies optimal target sequences with a minimum of potential off-target sites using the hg19 530 genome build (S2B and S2C Figs). 531 532
Transfection of HCEnC-21T Cells 533
The selected gRNA was hybridized to a complementary strand, and was subsequently ligated into 534 pSpCas9(BB)-2A-Puro (PX459) plasmid, a gift from Dr. Feng Zhang (Addgene plasmid #62988) 535
[54] (S2D Fig.) . Successfully transfected cells were selected and identified using media 536 containing puromycin. Transfection of the cells was verified by performing Western blots to 537 confirm the presence of the Cas9 protein (S2E Fig.) . 538
539
Clonal Expansion and Characterization 540
Limiting dilutions were performed to isolate single cells in 96-well plates. Viable cells identified 541 by microscopy were allowed to grow to confluence and were passaged and transferred to 24-well 542 plates. Mutants and controls clones were identified by Sanger sequencing and were transferred to 543 12-well plates. Genomic DNA was isolated from the clones using QuickExtract (Qiagen) and 544 ZEB1 was screened in each clone using Sanger sequencing (Laragen). CRISP-ID was used to 545 predict the sequences for each of the two alleles from the Sanger sequencing data that was 546 generated using diploid gDNA template (S3A Fig.) [55]. ZEB1 protein levels were measured 547 using an anti-ZEB1 rabbit monoclonal antibody (AB_1904164) diluted to 1:500 in 0.1% non-fat 548 dried milk in Tris buffered saline solution containing Tween 20. 549 550
Allele-specific sequencing 551
Amplicons generated from exon 4 from selected clones were subcloned into plasmid vectors 552 using a TA-cloning kit (Thermo Fisher Scientific)(S3 Fig.) . Plasmids containing one of two exon 553 4 alleles were isolated and screening of the cloned insert was performed using Sanger sequencing 554 (Laragen). The allele-specific sequencing method provided an unambiguous means for 555 identifying indels in each respective allele after CRISPR-Cas9 gene editing. Clones were further 556 characterized by Western blot to detect ZEB1 protein levels and phase-contrast microscopy to 557 assess cell morphology (S3B and S3C Figs). Clones 11 (ZEB1 +/+ ) and 12 (ZEB1 +/-) were selected 558 to establish cell lines representative of each genotype that was used in this study (S4 Fig.) . 559
560
Screening of off-target sites 561
As off-target editing by the CRISPR-Cas9 technique may alter cell function in unpredictable 562 ways, identification and screening of potential off-target sites was performed. Primers were 563 purchased from Integrated DNA Technologies and designed to screen each of the top 10 off-564 target sites predicted by the crispr.MIT.edu tool (S1 Table) . Sequencing of each site was 565 performed using Sanger sequencing (S5 Fig.) . To account for the possibility that only a prolonged/constitutive reconstituted expression of ZEB1 588 was capable of inducing rescue, we generated ZEB1 transgenic cell lines harboring either the 589
ZEB1
+/+ or ZEB1 +/-genotype. CEnC were transduced with either empty or ZEB1 lentivirus. Five 590 days after transduction, cell clones were isolated and expanded using the limited dilution method 591 by seeding 0.5 cells/well of a 96-well plate. Several clones were expanded for each CEnC group 592 (ZEB1 +/+ -LV, ZEB1 +/+ +LV, ZEB1 +/--LV and ZEB1 +/-+LV), and were subsequently 593 characterized by cell morphology and ZEB1 Western blot (rabbit monoclonal anti-ZEB1 antibody,AB_1904164). Three clones per cell group were chosen as independent biological lines (12 595 clones total, 3 per CEnC group). Assays to assess cell migration, cell morphology and lactate 596 transport function were performed with each of the respective clones representing a single 597 independent sample (n=1), so that three independent clones (n=3) were used for statistical 598
analysis. In addition, these 12 clones were used for RNA-seq and qPCR analysis. . Differential 610 expression was tested using a likelihood ratio test, and corrected for multiple testing using the 611
Benjamini-Hochberg correction. The following thresholds defined differential expression: fold 612 change (fc)> 2, TPM>15 and p-value<0.5 (PPCD data); fc>1.5, TPM>0.6 and p-value<0.2 (ZEB1 613 CEnC lines). Because the PPCD data was generated from two samples, we used a p-value of 0.5 614 to reduce false-positives. Given the relatively high variation between the cell lines within each 615 group, a p-value of 0.2 was used for DGE. While this may have increased the number of false-616 positives, the use of this p-value allowed genes known to be involved in EMT or regulated by 617 ZEB1 to be considered differentially expressed. We generated heatmaps using the pheatmap 618 function within the pheatmap (v1.0.10) R-package. RNA-seq data were obtained from the GEOepithelium, accession GSE121922). RNA-seq data for the cell lines were submitted to GEO 621
DataSets and assigned accession number GSE121680. 622
Distribution of differentially expressed genes in PPCD endothelium versus evCEnC and 623 evCEpC was statistically analyzed using two methods, a bootstrap approach and the 624 hypergeometric statistical test. The hypergeometric test (hgt) was performed as previously 625 described [58, 59] and was computed in R using the dhyper function with significance defined as 626 p<0.05. For the bootstrap method, we combined the Law of Large Numbers and the Central Limit 627
Theorem to create normal sampling distributions centered on the population mean for each of the 628 combinations of gene pools that were examined. We wrote a simulation in R 629
(https://zenodo.org/badge/latestdoi/154679145) and performed 10,000 iterations to create a 630 sampling distribution of the possible outcomes. The number of genes observed by experiment 631 was compared to the sampling distribution to find the probability (p-value) that the number 632 observed by experiment could have occurred by chance. Significance was defined by 0.95 > p < 633 0.05. 634
635
Immunohistochemistry 636
Full-thickness PPCD cornea obtained at the time of surgery and cadaveric donor cornea obtained 637 from an eye bank were fixed in 10% Formalin and embedded in paraffin. Tissue was sectioned at 638 a thickness of 5 µm and affixed to a frosted glass slide. Sections were deparaffinized in xylene 639 and rehydrated in an alcohol series. Antigen retrieval was performed with Proteinase K digestion, 640 and tissue was subsequently blocked in 5% goat serum and 1% bovine serum albumin. CLDN1 641 was detected using a rabbit monoclonal antibody (D5H1D; CST13255), and ADCYAP1R1 was 642 detected using a rabbit polyclonal antibody (AB_777009). Antibodies were diluted 1:1000 in 643 blocking buffer. Detection was performed using an anti-rabbit Alexa fluor conjugated secondary 644 antibody and visualized using a confocal fluorescence microscope. 645 
